Cancer Immunology & Tumor Microenvironment

Cancer immunology investigates how the immune system interacts with tumors, while tumor microenvironment (TME) studies the complex ecosystem surrounding cancer cells. This topic explores how tumors evade detection through immune checkpoints, altered antigen presentation, suppressive cytokines, and regulatory cell recruitment. The TME comprises immune cells, fibroblasts, vasculature, extracellular matrix, and metabolic conditions that shape tumor progression. Research addresses mechanisms of T-cell exhaustion, macrophage polarization, NK cell dysfunction, and the role of stromal elements in resistance to therapy. Advances in checkpoint inhibitors, CAR T-cell therapies, and personalized vaccines are transforming cancer treatment. Scientists are increasingly focusing on strategies to reprogram the TME, enhance tumor immunogenicity, and overcome barriers that limit immune cell infiltration. Multi-omics and single-cell technologies are providing insights into tumor–immune dynamics, supporting the development of next-generation immunotherapies and combination treatments.

    Related Conference of Cancer Immunology & Tumor Microenvironment

    May 18-19, 2026

    17th Global Summit on Immunology and Cell Biology

    Paris, Aland Islands

    Cancer Immunology & Tumor Microenvironment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in